Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Imaging of primary Ewing sarcoma with /sup 13/N-L-glutamate

Journal Article · · Radiology; (United States)
OSTI ID:5504998

Eleven patients with untreated primary Ewing sarcoma were studied with intravenously administered /sup 13/N-labeled L-glutamate. Seven were repeatedly scanned during chemotherapy using this agent and /sup 99m/Tc-methylene diphosphonate (/sup 99m/Tc-MDP). The untreated primary tumor was distinctly visualized with /sup 13/N-L-glutamate in all cases; the distribution of /sup 13/N label in the tumor sometimes differed from that of /sup 99m/Tc. A kinetic study showed rapid uptake of /sup 13/N by tumor tissue. Repeat scans following therapy indicated that /sup 13/N-L-glutamate and /sup 99m/Tc-MDP uptake showed changes consistent with histological findings following subsequent surgery. /sup 13/N uptake often decreased more markedly than /sup 99m/Tc uptake during chemotherapy, but metastatic lesions were not visualized with /sup 13/N-L-glutamate. Tumor imaging with this labeled amino acid may be of value in assessing the response of primary Ewing sarcoma to chemotherapy.

Research Organization:
Memorial Sloan-Kettering Cancer Center, New York
OSTI ID:
5504998
Journal Information:
Radiology; (United States), Journal Name: Radiology; (United States) Vol. 142:2; ISSN RADLA
Country of Publication:
United States
Language:
English